已收盘 02-06 16:00:00 美东时间
+9.000
+9.17%
今日重点评级关注:Canaccord Genuity:维持Wave Life Sciences Ltd."买入"评级,目标价从40美元升至43美元;花旗:维持Palantir Technologies"买入"评级,目标价从235美元升至260美元
02-04 12:15
Susquehanna analyst Mehdi Hosseini maintains Rambus (NASDAQ:RMBS) with a Neutral and lowers the price target from $100 to $90.
02-03 22:48
Rambus Inc. (NASDAQ: RMBS) shares down premarket as fourth quarter earnings report fails to boost investor sentiment. Record revenue and earnings not enough in mixed market environment.
02-03 21:30
U.S. stock futures were mostly higher this morning, with the Nasdaq 100 futures...
02-03 21:03
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Rambus业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **营收表现:** - Q4总营收1.902亿美元,超出内部预期 - 产品营收9,680万美元,同比增长32% - 全年产品营收3.478亿美元,同比增长41%,创年度新纪录 - 版税营收7,170万美元 - 硅IP营收2,180万美元 **盈利能力:** - Q4非GAAP净利润7,470万美元 - 全年毛利率61.5%,符合公司60%-65%的长期目标区间 - Q4运营成本1.032亿美元,其中运营费用6,490万美元,环比持平 **现金流表现:** - 全年运营现金流创
02-03 12:02
Rambus (NASDAQ:RMBS) released its Q4 earnings on Monday, February 2, 2026 at 04...
02-03 05:50